Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the ...

The Centers for Disease Control and Prevention estimates that in 2022, around 608,000 people died from malaria, a ...

The dengue virus is transmitted to ... such as Zika and Chikungunya viruses, with plasmin. They also aim to determine the crystal structure of the protein complex formed between plasmin kringle ...

Zika virus is currently present in over 90 countries and spreading at a rapid pace, thanks to Aedes aegypti mosquitoes, which also aid in the transmission of dengue and chikungunya. Scientists ...

In the three-dimensional structure of protein analysis ... Zika virus (ZIKV), Japanese encephalitis virus (JEV) and Chikungunya virus (CHIKV), following the identification of flavivirus. The primers ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8mL dose.

Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...

With the U.S. FDA’s approval of Vimkunya, Bavarian Nordic A/S is now in the chikungunya virus infection mix along with Valneva SE’s Ixchiq. A single-dose, adjuvanted virus-like particle-based vaccine ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...

No writing assistance was utilized in the production of this manuscript. Chikungunya virus (CHIKV) causes an acute febrile disease characterized by severe arthralgia in the small joints.